Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

793918

registered interest
date	22/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he has taken to improve the accessibility and affordability of medicines developed from publicly-funded research.
tabling member constituency	Peterborough
tabling member printed	Fiona Onasanya
uin	115007
answer	answer is ministerial correction date of answer 27/11/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) assesses medicines on the basis of their value to patients and to the National Health Service. The source of financial support in developing each medicine is not assessed.</p><p> </p><p>The NHS is required by law to ensure that all medicines recommended by NICE are funded within three months, ensuring patient access to cost-effective medicines in England. New medicines are not subject to payments under the voluntary Pharmaceutical Price Regulation Scheme, and NHS England monitors access to innovative medicines via the Innovation Scorecard in recognition of the value this Government places on innovation.</p><p> </p><p>Many countries fund research and development (R&amp;D), often at an early stage. Private companies invest in R&amp;D also. It is not possible to assess the contribution made by public investment or private investment in bringing products to market.</p><p> </p><p>The Government and its partners recently published the response to the Accelerated Access Review which sets out plans to give patients quicker access to life-changing treatments; and, make the United Kingdom the best place in the world for industry to invest and innovate. A total of £86 million of funding has already been committed to make the vision a reality.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/11/2017 16:42:41 answering member 4067 label Biography information for Steve Brine
tabling member	4629 label Biography information for Fiona Onasanya

794119

registered interest
date	22/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners: Halton
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many full-time equivalent GPs have been employed in the Halton CCG area in each year since 2012.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	115207
answer	answer is ministerial correction date of answer 27/11/2017 answer text <p>The table below indicates the number of full-time equivalent general practitioners (GPs) employed in Halton Clinical Commissioning Group (CCG) from 2012 untill September 2017.</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Full-Time Equivalent GPs</p></td></tr><tr><td><p>2017</p></td><td><p>75<sup>1</sup></p></td></tr><tr><td><p>2016</p></td><td><p>72</p></td></tr><tr><td><p>2015</p></td><td><p>72</p></td></tr><tr><td><p>2014</p></td><td><p>74<sup>2</sup></p></td></tr><tr><td><p>2013</p></td><td><p>66<sup>2</sup></p></td></tr><tr><td><p>2012</p></td><td><p>76<sup>2,3</sup></p></td></tr></tbody></table><p> </p><p>Notes:</p><p> </p><p>Data as of 30 September:</p><p><sup> </sup></p><p><sup>1</sup>Provisional data.</p><p><sup>2</sup>Excludes locums.</p><p><sup>3</sup>CCGs came into effect on 1 April 2013, for 2012 the figures are reflective of the practices which would subsequently constitute Halton CCG.</p><p> </p><p>Source: NHS Digital</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/11/2017 16:40:13 answering member 4067 label Biography information for Steve Brine
tabling member	429 label Biography information for Derek Twigg

794121

registered interest
date	22/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Commissioning Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, which CCG's have experienced a reduction in the number of referrals in 2017-18; and by what (a) percentage and (b) number of cases each such CCG's referrals have so reduced.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	115209
answer	answer is ministerial correction date of answer 27/11/2017 answer text <p>The information is not collected in the format requested and could only be obtained at disproportionate cost.</p><p> </p><p>Official statistics are published by NHS England throughout the year for specific work areas, including consultant-led referral to treatment and cancer waiting times. The publication calendar can be accessed online.</p><p> </p><p>This information is published at both provider and commissioner level and can be found at this link:</p><p><a href="https://www.england.nhs.uk/statistics/12-months-statistics-calendar/" target="_blank">https://www.england.nhs.uk/statistics/12-months-statistics-calendar/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/11/2017 16:45:54 answering member 4067 label Biography information for Steve Brine
tabling member	429 label Biography information for Derek Twigg

794124

registered interest
date	22/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sustainability and Transformation Partnerships: Operating Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the administrative costs have been for each of the 44 sustainability and transformation plans in England since their commencement.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	115212
answer	answer is ministerial correction date of answer 27/11/2017 answer text <p>Sustainability and Transformation Partnerships (STPs) are not statutory organisations, but a new way for the National Health Service and local government to work together.</p><p> </p><p>NHS England does not collect figures on the administrative costs of STPs. It is for each STP area to decide how best to staff and deliver their plan, bearing in mind the need to keep costs to a minimum.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/11/2017 16:43:51 answering member 4067 label Biography information for Steve Brine
tabling member	4036 label Biography information for Luciana Berger

792972

registered interest
date	21/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	GP at Hand
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 20 November 2017 to Question 112428, what the cost of the GP at hand service has been to the public purse to date.
tabling member constituency	Leigh
tabling member printed	Jo Platt
uin	114757
answer	answer is ministerial correction date of answer 29/11/2017 answer text <p>GP at Hand is a practice that holds a General Medical Service contract. Practices are paid per weighted registered patient and, as patients register or de-register with GP at Hand, this will alter the payment to the practice. Funding follows the registered patients, so if patients are leaving their current practice for GP at Hand the funding will move to that practice. The practice list sizes are counted and payments adjusted on the first of each quarter and so any payment adjustments will be made in January.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2017 17:06:52 answering member 4067 label Biography information for Steve Brine
tabling member	4673 label Biography information for Jo Platt

792973

registered interest
date	21/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	GP at Hand
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether his Department plans to rollout the GP at Hand service nationwide.
tabling member constituency	Leigh
tabling member printed	Jo Platt
uin	114758
answer	answer is ministerial correction date of answer 29/11/2017 answer text <p>GP at Hand is not a service that has been specifically commissioned by the Department or NHS England. It is a locally developed service commissioned by Hammersmith and Fulham Clinical Commissioning Group and operated by a general practice in London (Dr Jefferies and Partners) in collaboration with a private technology provider (Babylon).</p><p> </p><p>The Department and NHS England are following the development of the GP at Hand service to better understand how digital services can be adopted in a way that safeguards patients, delivers a quality service and supports the future sustainability of the National Health Service.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2017 17:09:06 answering member 4067 label Biography information for Steve Brine
tabling member	4673 label Biography information for Jo Platt

792987

registered interest
date	21/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the timetable is for the negotiations of the next Pharmaceutical Price Regulation Scheme.
tabling member constituency	Stockton South
tabling member printed	Dr Paul Williams
uin	114772
answer	answer is ministerial correction date of answer 27/11/2017 answer text <p>No decision has been made about the timing of negotiations with industry on medicines pricing arrangements for 2019 onwards. The Department has regular and ongoing dialogue with patient representative groups about medicines pricing and access issues, and all those views will help to inform discussions between the industry and the Department on the new arrangements.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 114773 question first answered 27/11/2017 16:41:41 answering member 4067 label Biography information for Steve Brine
tabling member	4666 label Biography information for Dr Paul Williams

792988

registered interest
date	21/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans his Department has to engage with patient groups on the contents of the next Pharmaceutical Price Regulation Scheme.
tabling member constituency	Stockton South
tabling member printed	Dr Paul Williams
uin	114773
answer	answer is ministerial correction date of answer 27/11/2017 answer text <p>No decision has been made about the timing of negotiations with industry on medicines pricing arrangements for 2019 onwards. The Department has regular and ongoing dialogue with patient representative groups about medicines pricing and access issues, and all those views will help to inform discussions between the industry and the Department on the new arrangements.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 114772 question first answered 27/11/2017 16:41:42 answering member 4067 label Biography information for Steve Brine
tabling member	4666 label Biography information for Dr Paul Williams

792989

registered interest
date	21/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the success of the Pharmaceutical Price Regulation Scheme in ensuring patients can access the most effective and innovative medicines.
tabling member constituency	Stockton South
tabling member printed	Dr Paul Williams
uin	114774
answer	answer is ministerial correction date of answer 29/11/2017 answer text <p>Use of innovative medicines in England is reported through the innovation scorecard. The most recent publication was in October 2017 and is available at:</p><p> </p><p><a href="https://digital.nhs.uk/catalogue/PUB30106" target="_blank">https://digital.nhs.uk/catalogue/PUB30106</a></p><p> </p><p>Since 2014, the medicines in the scorecard have changed as new medicines have become available. The scorecard shows that for the 12 months from April 2016 to March 2017, compared to the previous 12 months where comparable data is available, 73% of innovative medicines covered by the scorecard were prescribed more.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2017 14:40:57 answering member 4067 label Biography information for Steve Brine
tabling member	4666 label Biography information for Dr Paul Williams

792993

registered interest
date	21/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, in which ten areas of England do residents have the longest travel times to their nearest radiotherapy units.
tabling member constituency	Westmorland and Lonsdale
tabling member printed	Tim Farron
uin	114778
answer	answer is ministerial correction date of answer 29/11/2017 answer text <p>This information is not held centrally.</p><p> </p><p>Public Health England advises that a postcode-level dataset that will enable the calculation of travel times to radiotherapy units is currently in development by the National Cancer Registry and Analysis Service. Results will be published in 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2017 17:14:42 answering member 4067 label Biography information for Steve Brine
tabling member	1591 label Biography information for Tim Farron